Antibacterial drugs market global industry analysis, size, share, growth, trends and forecast, 2013 - 2019

  • Published on
    14-Sep-2014

  • View
    418

  • Download
    0

Embed Size (px)

DESCRIPTION

According to a new market report published by Transparency Market Research "Antibacterial Drugs Market (By Class- Aminoglycosides, -Lactams, Tetracyclines, Sulfonamides, Quinolones/Fluoroquinolones, Macrolides and Phenicols, and Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global antibacterial drugs market was valued at USD 43.55billion in 2012 and is expected to grow at a CAGR of0.3% from 2013 to 2019, to reach an estimated value of USD 45.09billion in 2019. Browse Global Antibacterial Drugs Market Report with Full TOC: http://www.transparencymarketresearch.com/antibacterial-drugs-market.html

Transcript

<ul><li><p>REPORT DESCRIPTION </p><p>Antibacterial Drugs Market Expected to Reach USD 45.09 Billion Globally in 2019: </p><p>Transparency Market Research </p><p>According to a new market report published by Transparency Market Research </p><p>"Antibacterial Drugs Market (By Class- Aminoglycosides, -Lactams, Tetracyclines, </p><p>Sulfonamides, Quinolones/Fluoroquinolones, Macrolides and Phenicols, and </p><p>Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and </p><p>Forecast, 2013 - 2019," the global antibacterial drugs market was valued at USD </p><p>43.55billion in 2012 and is expected to grow at a CAGR of0.3% from 2013 to 2019, to reach </p><p>an estimated value of USD 45.09billion in 2019. </p><p>Browse Global Antibacterial Drugs Market Report with Full TOC: </p><p>http://www.transparencymarketresearch.com/antibacterial-drugs-market.html </p><p>An antibacterial drug has been utilized by humans since the discovery of the first antibiotic </p><p>penicillin in 1928 and has grown into a multi-billion dollar market since. These drugs treat </p><p>infectious diseases caused by gram positive, gram negative, aerobic and anaerobic bacteria, </p><p>which cannot be treated by any other method unlike other diseases, where substitute </p><p> Transparency Market Research </p><p> Antibacterial Drugs Market </p><p>- Global Industry Analysis, Size, Share, Growth, </p><p>Trends and Forecast, 2013 - 2019 Single User License: US $ 4595 </p><p> Multi User License: US $ 7595 </p><p> Corporate User License: US $ 10595 </p><p> Buy Now Request Sample </p><p>Published Date: Apr 2014 </p><p> 110 Pages Report </p></li><li><p>methodologies are available. This property has made antibacterial drugs an indispensable </p><p>part of human healthcare. </p><p>Antibacterial drugs are classified into seven major classes, namely, aminoglycosides, -</p><p>Lactams, tetracyclines, sulfonamides, quinolones, macrolides and phenicols. The -lactams </p><p>class was the largest segment of the global antibacterial drugs market in 2012,with 57% </p><p>share.Quinolones was identified as the second largest class, which held a share of 16.6% of </p><p>the global antibacterial drugs market in 2012 and is expected to report a negative CAGR </p><p>during the forecast period. This decline in revenue will be primarily witnessed due to sales </p><p>erosion from patent expiries, evolution of resistant strains of bacteria and rising concerns </p><p>regarding tendon ruptures and tendon damage from fluoroquinolones therapy.However, the </p><p>demand for macrolides and quinolones/fluoroquinolones classes will remain high during the </p><p>forecast period, due to their usage in treating a large number of infections coupled with </p><p>expected launch of pipeline drugs in these classes during the forecast period. </p><p>Factors such as increasing prevalence of infectious diseases and rising demand for effective </p><p>as well as affordable antibacterial drugs especially from emerging economies of Asia-Pacific, </p><p>Latin America, Middle East and Africa are the major growth drivers for the antibacterial </p><p>drugs market. Globally, rise in elderly population is also being considered as one of the </p><p>major growth factors as it will indirectly increase the demand for various antibacterial drugs. </p><p>The demand for antibacterial drugs will continue to rise regardless of presence of a wide </p><p>range of antibacterial drugs. This is mainly due to increased prevalenceof resistant species </p><p>which demand development of innovative molecules. </p><p>In 2012, Asia-Pacific held the largest share of the revenue generated by the global </p><p>antibacterial drugs market. This region is also set to experience the highest growth rate </p><p>during the forecast period 2013 to 2019. This is becausethe region accounts for the largest </p><p>infected population in the world, by a variety of bacterial infections like pneumonia, </p><p>tuberculosis, tetanus and others. Other factors includeincreasing multi-drug resistant </p><p>bacterial strains, increasing availability of generic drugs and increasing purchasing power of </p><p>the people of this region. India, one of the key markets in the Asia-Pacific region, isfamous </p><p>for being the largest generic drug manufacturing nation. North America held the second </p><p>largest revenue share, followed by Europe in the antibacterial drugs market in 2012. </p></li><li><p>At present, certain novel compounds are under investigation in both preclinical and clinical </p><p>settings for the treatment of newly evolving drug-resistant bacterial species.Some of the </p><p>major candidates such as Dalvance (Durata Therapeutics), tedizolidand surotomycin(Cubist </p><p>Pharmaceuticals), and others are currently in phase III clinical trials. These drugs promise </p><p>to provide improved efficacy, shorter onset of action and fewer side effects as compared to </p><p>the currently available antibacterial drugs. Hence, expected launch of these drugs during </p><p>the forecast period is anticipated to have a profound impact on the growth of the overall </p><p>antibacterial drugs market. </p><p>AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly and Company, Forest </p><p>Laboratories, Inc., GlaxoSmithKline plc, Johnson &amp; Johnson, Merck &amp; Co., Inc., Novartis AG, </p><p>Pfizer, Inc., and Sanofi are the major players operating in the global antibacterial drugs </p><p>market. With very few patented products currently available in this market, the market is </p><p>currently dominated by generic manufacturers to a great extent. With respect to the key </p><p>revenue generating drugs (branded and generic) of this market, Pfizer, Inc. accounted for </p><p>the largest market share in 2012, followed by Merck &amp; Co., Inc. and GlaxoSmithKline plc. </p><p>The global antibacterial drugs market is segmented as follows: </p><p>Antibacterial Drugs Market, by Class </p><p> Aminoglycosides </p><p> -Lactams </p><p> Tetracyclines </p><p> Sulfonamides </p><p> Quinolones/Fluoroquinolones </p><p> Macrolides </p><p> Phenicols </p><p>Antibacterial Drugs Market, by Geography </p><p> North America </p><p> Europe </p><p> Asia-Pacific </p><p> Rest of the World (RoW) </p></li><li><p>Browse Global Antibacterial Drugs Market Report with Full TOC: </p><p>http://www.transparencymarketresearch.com/antibacterial-drugs-market.html </p><p>TABLE OF CONTENTS </p><p>Chapter 1 Preface </p><p>1.1 Report Description </p><p>1.2 Market Segmentation </p><p>1.3 Research Methodology </p><p> 1.3.1 Sources </p><p> 1.3.1.1 Secondary Research </p><p> 1.3.1.2 Primary Research </p><p>Chapter 2 Executive Summary </p><p>Chapter 3 Market Overview </p><p>3.1 Introduction to Antibacterial Drugs </p><p>3.2 Market Trends and Future Outlook </p><p> 3.2.1 Impact of generics </p><p>3.3 Market Drivers </p><p> 3.3.1 Global increasing prevalence of a large number of infectious diseases </p><p> 3.3.2 Rising demand for effective and affordable antibacterial drugs from emerging </p><p>economies </p><p> 3.3.3 Aging population </p><p>3.4 Market Restraints </p></li><li><p>Related &amp; Recently Published Reports by Transparency Market Research </p><p>Orthopedic Soft Tissue Repair Market: </p><p>http://www.transparencymarketresearch.com/soft-tissue-repair-sports-medicine.html </p><p>Nanocoatings Market: http://www.transparencymarketresearch.com/nanocoatings-</p><p>market.html </p><p>Calcium Carbonate Market: http://www.transparencymarketresearch.com/calcium-</p><p>carbonate-market.html </p><p> 3.4.1 Weak pipeline of novel antibacterial drugs </p><p> 3.4.2 Patent expirations </p><p> 3.4.3 Rising number of generic drugs in various antibacterial drug classes </p><p> 3.4.4 Increasing number of multi-drug resistant bacterial strains </p><p>3.5 Market Opportunities </p><p> 3.5.1 Product differentiation through technological innovation, use of monoclonal </p><p>antibodies (mAbs), combination products, new formulations and indications </p><p> 3.5.2 Product development through partnerships </p><p>3.6 Porters Five Forces Analysis for the Global Antibacterial Drugs Market </p><p> 3.6.1 Bargaining power of suppliers </p><p> 3.6.2 Bargaining power of buyers </p><p> 3.6.3 Threat of substitutes </p><p> 3.6.4 Threat of new entrants </p><p> 3.6.5 Competitive rivalry </p><p>3.7 Market Attractiveness Analysis: Global Antibacterial Drugs Market, by Geography </p></li><li><p>Browse Global Antibacterial Drugs Market Report with Full TOC: </p><p>http://www.transparencymarketresearch.com/antibacterial-drugs-market.html </p><p>Chapter 4 Global Antibacterial Drugs Market Revenue, by Class, 2011 - 2019 (USD Million) </p><p>4.1 Overview </p><p> 4.1.1 Global Antibacterial Drugs Market Revenue, by Class, 2011 2019 (USD Million) </p><p> 4.1.2 Comparative Analysis: Global Antibacterial Drugs Market Revenue, by Class, </p><p>2012 &amp; 2019 (Value %) </p><p>4.2 Aminoglycosides </p><p> 4.2.1 Global Aminoglycosides Market Revenue, 2011 2019 (USD Million) </p><p>4.3 B-Lactams </p><p> 4.3.1 Global B-Lactams Market Revenue, 2011 2019 (USD Million) </p><p> 4.3.2 Penicillins </p><p> 4.3.3 Carbapenems </p><p> 4.3.4 Cephalosporins </p><p>4.4 Tetracyclines </p><p> 4.4.1 Global Tetracyclines Market Revenue, 2011 2019 (USD Million) </p><p>4.5 Sulfonamides </p><p> 4.5.1 Global Sulfonamides Market Revenue, 2011 2019 (USD Million) </p><p>4.6 Quinolones/Fluoroquinolones </p><p> 4.6.1 Global Quinolones/Fluoroquinolones Market Revenue, 2011 2019 (USD Million) </p><p>4.7 Macrolides </p></li><li><p> 4.7.1 Global Macrolides Market Revenue, 2011 2019 (USD Million) </p><p>4.8 Phenicols </p><p> 4.8.1 Global Phenicols Market Revenue, 2011 2019 (USD Million) </p><p>Chapter 5 Global Antibacterial Drugs Market Revenue, Pipeline Analysis (USD </p><p>Million) </p><p>5.1 Overview </p><p>5.2 Delafloxacin (RX-3341) </p><p> 5.2.1 Global Delafloxacin Market, 2015 2019 (USD Million) </p><p>5.3 Surotomycin (CB-315) </p><p> 5.3.1 Global Surotomycin Market, 2016 2019 (USD Million) </p><p>5.4 Tedizolid (TR-701) </p><p> 5.4.1 Global Tedizolid Market, 2015 2019 (USD Million) </p><p>5.5 Ceftolozane/Tazobactam </p><p> 5.5.1 Global Ceftolozane/Tazobactam Market, 2015 2019 (USD Million) </p><p>5.6 Dalvance (dalbavancin) </p><p> 5.6.1 Global Dalvance (dalbavancin) Market, 2015 2019 (USD Million) </p><p>5.7 Eravacycline (TP-434) </p><p> 5.7.1 Global Eravacycline Market, 2016 2019 (USD Million) </p><p>5.8 Delamanid (OPC-67683) </p><p> 5.8.1 Global Delamanid Market, 2017 2019 (USD Million) </p><p>5.9 CAZ AVI </p></li><li><p>Browse Global Antibacterial Drugs Market Report with Full TOC: </p><p>http://www.transparencymarketresearch.com/antibacterial-drugs-market.html </p><p> 5.9.1 Global CAZ AVI Market, 2015 2019 (USD Million) </p><p>5.10 Solithromycin (CEM-101) </p><p> 5.10.1 Global Solithromycin Market, 2016 2019 (USD Million) </p><p>5.11 MK-3415A </p><p> 5.11.1 Global MK-3415A Market, 2016 2019 (USD Million) </p><p>5.12 Oritavancin </p><p> 5.12.1 Global Oritavancin Market, 2015 2019 (USD Million) </p><p>Chapter 6 Global Antibacterial Drugs Market Revenue, by Geography, 2011 - 2019 </p><p>(USD Million) </p><p>6.1 Overview </p><p> 6.1.1 Global Antibacterial Drugs Market Revenue, by Geography, 2011 2019 (USD </p><p>Million) </p><p> 6.1.2 Comparative Analysis: Global Antibacterial Drugs Market Revenue, by </p><p>Geography, 2012 &amp; 2019 (Value %) </p><p>6.2 North America </p><p> 6.2.1 North America Antibacterial Drugs Market Revenue, 2011 - 2019 (USD Million) </p><p>6.3 Europe </p><p> 6.3.1 Europe Antibacterial Drugs Market Revenue, 2011 - 2019 (USD Million) </p><p>6.4 Asia-Pacific </p></li><li><p>Browse Global Antibacterial Drugs Market Report with Full TOC: </p><p>http://www.transparencymarketresearch.com/antibacterial-drugs-market.html </p><p> 6.4.1 Asia-Pacific Antibacterial Drugs Market Revenue, 2011 - 2019 (USD Million) </p><p>6.5 Rest of the World (RoW) </p><p> 6.5.1 RoW Antibacterial Drugs Market Revenue, 2011 - 2019 (USD Million) </p><p>Chapter 7 Competitive Landscape </p><p>7.1 Market Share Analysis: Global Antibacterial Drugs Market (2012) </p><p>Chapter 8 Recommendations </p><p>8.1 Development of combination products </p><p>8.2 Generic pharmaceuticals: Targeting emerging markets such as India, China, Brazil, </p><p>Mexico and South Africa </p><p>8.3 Strategic collaborations with small biotechnology and research companies </p><p>Chapter 9 Company Profiles </p><p>9.1 AstraZeneca plc </p><p> 9.1.1 Company Overview </p><p> 9.1.2 Financial Overview </p><p> 9.1.3 Product Portfolio </p><p> 9.1.4 Business Strategies </p><p> 9.1.5 Recent Developments </p></li><li><p>9.2 Bayer AG </p><p> 9.2.1 Company Overview </p><p> 9.2.2 Financial Overview </p><p> 9.2.3 Product Portfolio </p><p> 9.2.4 Business Strategies </p><p> 9.2.5 Recent Developments </p><p>9.3 Bristol-Myers Squibb Company </p><p> 9.3.1 Company Overview </p><p> 9.3.2 Financial Overview </p><p> 9.3.3 Product Portfolio </p><p> 9.3.4 Business Strategies </p><p> 9.3.5 Recent Developments </p><p>9.4 Eli Lilly and Company </p><p> 9.4.1 Company Overview </p><p> 9.4.2 Financial Overview </p><p> 9.4.3 Product Portfolio </p><p> 9.4.4 Business Strategies </p><p> 9.4.5 Recent Developments </p><p>9.5 Forest Laboratories, Inc. </p><p> 9.5.1 Company Overview </p><p> 9.5.2 Financial Overview </p></li><li><p> 9.5.3 Product Portfolio </p><p> 9.5.4 Business Strategies </p><p> 9.5.5 Recent Developments </p><p>9.6 GlaxoSmithKline plc </p><p> 9.6.1 Company Overview </p><p> 9.6.2 Financial Overview </p><p> 9.6.3 Product Portfolio </p><p> 9.6.4 Business Strategies </p><p> 9.6.5 Recent Developments </p><p>9.7 Johnson &amp; Johnson </p><p> 9.7.1 Company Overview </p><p> 9.7.2 Financial Overview </p><p> 9.7.3 Product Portfolio </p><p> 9.7.4 Business Strategies </p><p> 9.7.5 Recent Developments </p><p>9.8 Merck &amp; Co., Inc. </p><p> 9.8.1 Company Overview </p><p> 9.8.2 Financial Overview </p><p> 9.8.3 Product Portfolio </p><p> 9.8.4 Business Strategies </p><p> 9.8.5 Recent Developments </p></li><li><p>Browse Global Antibacterial Drugs Market Report with Full TOC: </p><p>http://www.transparencymarketresearch.com/antibacterial-drugs-market.html </p><p>9.9 Novartis AG </p><p> 9.9.1 Company Overview </p><p> 9.9.2 Financial Overview </p><p> 9.9.3 Product Portfolio </p><p> 9.9.4 Business Strategies </p><p> 9.9.5 Recent Developments </p><p>9.10 Pfizer, Inc. </p><p> 9.10.1 Company Overview </p><p> 9.10.2 Financial Overview </p><p> 9.10.3 Product Portfolio </p><p> 9.10.4 Business Strategies </p><p> 9.10.5 Recent Developments </p><p>9.11 Sanofi </p><p> 9.11.1 Company Overview </p><p> 9.11.2 Financial Overview </p><p> 9.11.3 Product Portfolio </p><p> 9.11.4 Business Strategies </p><p> 9.11.5 Recent Developments </p></li><li><p>About Us: </p><p>Transparency Market Research is a market intelligence company providing global business </p><p>information reports and services. Our exclusive blend of quantitative forecasting and trends </p><p>analysis provides forward-looking insight for thousands of decision makers. </p><p>We are privileged with highly experienced team of Analysts, Researchers and Consultants, </p><p>who use proprietary data sources and various tools and techniques to gather, and analyze </p><p>information. Our business offerings represent the latest and the most reliable information </p><p>indispensable for businesses to sustain a competitive edge. </p><p>Contact: </p><p>Transparency Market Research </p><p>90 State Street, </p><p>Suite 700, </p><p>Albany </p><p>NY - 12207 </p><p>United States </p><p>Tel: +1-518-618-1030 </p><p>USA - Canada Toll Free 866-552-3453 </p><p>Email: sales@transparencymarketresearch.com </p><p>Website: http://www.transparencymarketresearch.com/ </p><p>Browse Global Antibacterial Drugs Market Report with Full TOC: </p><p>http://www.transparencymarketresearch.com/antibacterial-drugs-market.html </p></li></ul>